Guiyang Xintian Pharmaceutical Co Ltd (002873) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Guiyang Xintian Pharmaceutical Co Ltd (002873) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥48.81 Million ≈ $7.14 Million USD) by net assets (CN¥1.26 Billion ≈ $184.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002873 net asset quality score to measure how much of total assets are equity-financed.

Guiyang Xintian Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Guiyang Xintian Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002873 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Guiyang Xintian Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guiyang Xintian Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Wistron Information Technology & Services TWO:4953	0.134x
SCHMID Group N.V. Class A Ordinary Shares NASDAQ:SHMD	-0.004x
Long Yuan Construction Group Co Ltd SHG:600491	0.027x
KS Terminals Inc TW:3003	0.040x
Advanced Ceramic X TWO:3152	0.017x
Chung Hwa Chemical Industrial Works Ltd TW:1727	-0.018x
Eveready Industries India Limited NSE:EVEREADY	0.066x
Grindrod Shipping Holdings Ltd NASDAQ:GRIN	0.127x

Annual Cash Flow Conversion Efficiency for Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Guiyang Xintian Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.26 Billion ≈ $183.83 Million	CN¥83.73 Million ≈ $12.25 Million	0.067x	-9.64%
2024-12-31	CN¥1.19 Billion ≈ $174.82 Million	CN¥88.13 Million ≈ $12.90 Million	0.074x	+5.59%
2023-12-31	CN¥1.11 Billion ≈ $162.92 Million	CN¥77.78 Million ≈ $11.38 Million	0.070x	+4.05%
2022-12-31	CN¥1.13 Billion ≈ $165.24 Million	CN¥75.82 Million ≈ $11.09 Million	0.067x	-51.90%
2021-12-31	CN¥890.44 Million ≈ $130.30 Million	CN¥124.30 Million ≈ $18.19 Million	0.140x	-34.22%
2020-12-31	CN¥828.30 Million ≈ $121.21 Million	CN¥175.77 Million ≈ $25.72 Million	0.212x	+345.92%
2019-12-31	CN¥708.76 Million ≈ $103.71 Million	CN¥33.73 Million ≈ $4.94 Million	0.048x	-33.95%
2018-12-31	CN¥660.59 Million ≈ $96.66 Million	CN¥47.59 Million ≈ $6.96 Million	0.072x	-27.78%
2017-12-31	CN¥622.11 Million ≈ $91.03 Million	CN¥62.06 Million ≈ $9.08 Million	0.100x	-54.60%
2016-12-31	CN¥279.21 Million ≈ $40.86 Million	CN¥61.34 Million ≈ $8.98 Million	0.220x	+22.08%
2015-12-31	CN¥226.31 Million ≈ $33.12 Million	CN¥40.73 Million ≈ $5.96 Million	0.180x	-8.09%
2014-12-31	CN¥190.50 Million ≈ $27.88 Million	CN¥37.30 Million ≈ $5.46 Million	0.196x	+122.05%
2013-12-31	CN¥157.38 Million ≈ $23.03 Million	CN¥13.88 Million ≈ $2.03 Million	0.088x	-26.49%
2012-12-31	CN¥178.44 Million ≈ $26.11 Million	CN¥21.41 Million ≈ $3.13 Million	0.120x	--

About Guiyang Xintian Pharmaceutical Co Ltd

SHE:002873 China Biotechnology

Market Cap

$279.69 Million

CN¥1.91 Billion CNY

Market Cap Rank

#15111 Global

#4455 in China

Share Price

CN¥7.83

Change (1 day)

+1.95%

52-Week Range

CN¥7.16 - CN¥15.19

All Time High

CN¥103738.98